The PREVENT study aims to prevent epilepsy caused by neonatal

encephalopathy in India by implementation of a pragmatic intrapartum care bundle. The first phase of our study has been completed and we have now moved on to the second phase on 1st of March 2022. The site investigators met face to face at Bengaluru in February 2022 for discussing the potential site specific challenges with respect to the implementation of care bundle and came up with the optimum approach. As the second phase began, we organized a formal dissemination event and the care bundle is now actively implemented across all the sites. So far, we have enrolled more than 45,000 mothers for the study. We also diligently continue with our academic sessions for team such as multi country journal clubs, weekly EEG training sessions and also the PhD programmes.

We are excited to share our stories across the three sites-Bangalore, Calicut and Hubli, towards achieving the nearly impossible 30,000 plus recruitment milestone, despite all the hardships and challenges. This is an occasion for thanksgiving to NIHR and our collaborators who constantly support the execution of our project and our team members for their consistent efforts and dedication towards this achievement. With this momentum, we are ready to kickstart the second phase, through adopting wide of range optimised strategies in consultation with global experts in order to achieve our goals and priorities and to drive for a world class impact on saving babies.